# Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice

> **NCT02783976** · — · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 25 (actual)

## Conditions studied

- HCV Infection

## Interventions

- **DRUG:** Sovaldi

## Key facts

- **NCT ID:** NCT02783976
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-28
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02783976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02783976, "Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02783976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*